Biological meshes for abdominal hernia: Lack of evidence-based recommendations for clinical use

被引:16
|
作者
Trippoli, Sabrina [1 ]
Caccese, Erminia [1 ]
Tulli, Giorgio [2 ]
Ipponi, Pierluigi [3 ]
Marinai, Claudio [1 ]
Messori, Andrea [1 ]
机构
[1] ESTAR, HTA Unit, Reg Hlth Serv, I-50135 Florence, Italy
[2] Reg Hlth Agcy, Florence, Italy
[3] Surg Unit, Florence, Italy
关键词
Abdominal surgery; Biological meshes; Synthetic meshes; Post-surgical infection; Post-surgical recurrence; Meta-analysis; WALL RECONSTRUCTION; TERM OUTCOMES; REPAIR; PERMACOL(TM); MATRIX; REINFORCEMENT; METAANALYSIS; DEFECTS; IMPLANT; IMPACT;
D O I
10.1016/j.ijsu.2018.02.046
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: In the clinical literature on abdominal hernia repair, no sound criteria have been established to support the use of biological meshes as opposed to synthetic ones. Furthermore, the information on biological meshes is quite scarce, and so their place in therapy has not yet been defined. Methods: The treatment of primary and incisional ventral hernia was the target intervention evaluated in our analysis. Our study consisted of the following phases: a) Identification of the biologic meshes available on the market; b) Literature search focused on efficacy and safety of these meshes; c) Analysis of the findings derived from the literature search. The information collected this way was reviewed narratively, and presented according to standard meta-analysis. The main end-points of our analysis included infection of surgical wound at 1 month and recurrence at 12 months. Results: Our clinical literature comprised 11 trials that evaluated 5 biological meshes: Permacol (706 patients), Strattice (324 patients), Surgisis (44 patients), Tutomesh (38 patients) and Xenmatrix (22 patients). These studies generally showed a poor methodological quality. Surgical wound infection showed a wide between-study variability (95% CI: from 12.0% to 22.9%). Also the 12-month relapse rate demonstrated a wide 95% CI (from 5.0% to 19.9%). A significantly lower rate of recurrence at 12 months was found for Permacol compared with Strattice (rate difference: -14.2%; 95% CI: -22.1% to -6.2%). Discussion: Our analysis provided an overview of 5 biological meshes currently available on the market. The different types of meshes showed a marked statistical variability in the clinical outcomes. Hence, nearly all comparisons between different meshes in the two clinical end-points did not reach statistical significance. One exception was represented by the finding that cross-linked meshes had a significantly lower recurrence rate at 12 months than non-cross-linked meshes.
引用
收藏
页码:286 / 292
页数:7
相关论文
共 50 条
  • [41] Evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning
    Gosselin, Sophie
    Hoegberg, Lotte C. G.
    Hoffman, Robert. S.
    Graudins, Andis
    Stork, Christine M.
    Thomas, Simon H. L.
    Stellpflug, Samuel J.
    Hayes, Bryan D.
    Levine, Michael
    Morris, Martin
    Nesbitt-Miller, Andrea
    Turgeon, Alexis F.
    Bailey, Benoit
    Calello, Diane P.
    Chuang, Ryan
    Bania, Theodore C.
    Megarbane, Bruno
    Bhalla, Ashish
    Lavergne, Valery
    CLINICAL TOXICOLOGY, 2016, 54 (10) : 899 - 923
  • [42] Correction: Consensus evidence-based clinical practice recommendations for the management of fibromyalgia
    Yasser El Miedany
    Naglaa Gadallah
    Diaa Mohasseb
    Nahla M. Gaballah
    Abeer K. El Zohiery
    Mohammed Hassan
    Maha El Gaafary
    Waleed Hassan
    Mohamed Mortada
    Mervat Eissa
    Samar Abdelhamed Tabra
    Nermeen Foad
    Fatma H. El Nouby
    Sally Saber
    Salwa Galal
    Egyptian Rheumatology and Rehabilitation, 2022, 49
  • [43] TREATING TO TARGET OF PSORIASIS: AN EVIDENCE-BASED CONSENSUS ON CLINICAL PRACTICE RECOMMENDATIONS
    El Miedany, Y.
    Abu-Zaid, M. H.
    Elgaafary, M.
    Ali, N.
    Mansour, M.
    Fathi, N.
    Hassan, W.
    Mortada, M. A.
    Moussa, S.
    Eissa, M.
    Tabra, S. A. A.
    Fouad, N.
    Ali, R.
    Medhat, B. M.
    Jamaleldeen, J.
    Hussein, Y. Adel Abdelsalam
    Ghaleb, R. M.
    Elameen, E. Nourhan
    Dessouki, E.
    Saber, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1583 - 1584
  • [44] Clinical approach to fibromyalgia: Synthesis of Evidence-based recommendations, a systematic review
    Angel Garcia, Daniel
    Martinez Nicolas, Ismael
    Saturno Hernandez, Pedro J.
    REUMATOLOGIA CLINICA, 2016, 12 (02): : 65 - 71
  • [45] Evidence-Based Clinical Recommendations for the Administration of the Sequential Motion Rates Task
    Icht, Michal
    Ben-David, Boaz M.
    COMMUNICATION DISORDERS QUARTERLY, 2018, 39 (03) : 442 - 448
  • [46] Evidence-based Recommendations for Spine Surgery
    Vaccaro, Alexander R.
    Fisher, Charles G.
    SPINE, 2022, 47 (13) : 965 - 966
  • [47] Evidence-Based Recommendations for Spine Surgery
    Fisher, Charles G.
    Vaccaro, Alexander R.
    Whang, Peter G.
    Prasad, Srinivas K.
    Angevine, Peter D.
    Mulpuri, Kishore
    Thomas, Kenneth C.
    Patel, Alpesh A.
    SPINE, 2011, 36 (14) : E897 - E903
  • [48] Evidence-Based Recommendations for Spine Surgery
    He, Junbo
    Wu, Tingkui
    Liu, Hao
    SPINE, 2020, 45 (21) : E1449 - E1449
  • [49] Evidence-Based Recommendations for Spine Surgery
    Fisher, Charles G.
    Vaccaro, Alexander R.
    Patel, Alpesh A.
    Whang, Peter G.
    Thomas, Ken C.
    Chi, John
    Mulpuri, Kishore
    Prasad, Srinivas K.
    SPINE, 2020, 45 (12) : 851 - 859
  • [50] Recommendations for prevention and evidence-based medicine
    Gohlke, H
    Schuler, G
    ZEITSCHRIFT FUR KARDIOLOGIE, 2005, 94 (Suppl 3): : 1 - 5